We observed higher HAS2 expression in UMUC3 and T24T shAGL cells (Fig. 1a, b) as reported previously and the siHAS2 reduces its expression in the shCTL and shAGL bladder cancer cells (Fig. 1a, b). This evidence concerns the gene HAS2 and urinary bladder carcinoma.